The clinical utility of an <i>SCN1A</i> genetic diagnosis in infantile‐onset epilepsy

Abstract

In addition to confirming a clinical diagnosis, a positive SCN1A test result influenced treatment choice and assisted in accessing additional therapies, especially in the very young.